Epigenetic Regulation Mediated by Sphingolipids in Cancer

Epigenetic Regulation Mediated by Sphingolipids in Cancer

Epigenetic changes are heritable modifications that do not directly affect the DNA sequence. In cancer cells, the maintenance of a stable epigenetic profile can be crucial to support survival and proliferation, and said profile can differ significantly from that of healthy cells. The epigenetic prof...

Full description

Bibliographic Details
Main Authors:	Nicolò Bozzini, Sofia Avnet, Nicola Baldini, Margherita Cortini
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	epigenetics cancer sphingolipids tumour microenvironment hypoxia acidosis
Online Access:	https://www.mdpi.com/1422-0067/24/6/5294

Similar Items

Acid Microenvironment in Bone Sarcomas
by: Gemma Di Pompo, et al.
Published: (2021-07-01)

Pre-clinical Models for Studying the Interaction Between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness
by: Sofia Avnet, et al.
Published: (2019-04-01)

Epigenetic regulation and therapeutic targets in the tumor microenvironment
by: Zhuojun Xie, et al.
Published: (2023-06-01)

Epigenetic aspects in rehabilitation of female cancer patients
by: A. G. Solopova, et al.
Published: (2022-07-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
by: Emily J. Kay, et al.
Published: (2023-04-01)

Sphingolipid biology /
by: Hirabayashi, Yoshio, et al.
Published: (2006)

Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic Target
by: Margherita Cortini, et al.
Published: (2021-01-01)

New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment
by: Margherita Cortini, et al.
Published: (2019-06-01)

Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling
by: Andrea Huwiler, et al.
Published: (2023-03-01)

Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors
by: Olga eSedlakova, et al.
Published: (2014-01-01)

Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases
by: Gemma Di Pompo, et al.
Published: (2022-08-01)

Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
by: Konstantinos Avgoustakis, et al.
Published: (2024-01-01)

The Implication of Sphingolipids in Viral Infections
by: Sanya Thomas, et al.
Published: (2023-12-01)

Dysregulation of sphingolipid metabolism in pain
by: Jianfeng Wang, et al.
Published: (2024-03-01)

The Role of Sphingolipids in Cancer Immunotherapy
by: Paola Giussani, et al.
Published: (2021-06-01)

Editorial: Sphingolipid metabolism and cancer
by: Margarita M. Ivanova, et al.
Published: (2022-11-01)

Targeting Sphingolipids for Cancer Therapy
by: Osmel Companioni, et al.
Published: (2021-10-01)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
by: Daniela N. Petrusca, et al.
Published: (2022-06-01)

Biomimetic nanomaterial-facilitated oxygen generation strategies for enhancing tumour treatment outcomes
by: Zhongwen Yang, et al.
Published: (2022-10-01)

Epigenetic regulation in cancer
by: Minzhi Gu, et al.
Published: (2024-02-01)

Sphingolipid Mediators of Myocardial Pathology
by: Anna Kovilakath, et al.
Published: (2020-01-01)

ORMDL3 and Asthma: Linking Sphingolipid Regulation to Altered T Cell Function
by: Christopher R. Luthers, et al.
Published: (2020-11-01)

Optical Control of Glycerolipids and Sphingolipids
by: Johannes Morstein, et al.
Published: (2021-12-01)

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
by: Shinjini Bandopadhyay, et al.
Published: (2023-08-01)

Editorial: Sphingolipid metabolism dysfunction in cancer
by: Rashika El Ridi, et al.
Published: (2023-06-01)

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
by: Laura R. Moffitt, et al.
Published: (2020-10-01)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2022-05-01)

By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

Editorial: Sphingolipids in Infection Control
by: Jürgen Seibel, et al.
Published: (2021-06-01)

Epigenetic heterogeneity in cancer
by: Mingzhou Guo, et al.
Published: (2019-10-01)

Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
by: Yujian Zhong, et al.
Published: (2022-10-01)

Sphingolipids in neurodegenerative diseases
by: Xueyang Pan, et al.
Published: (2023-02-01)

Sphingolipids in plant immunity
by: Hong-Yun Zeng, et al.
Published: (2022-06-01)

Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling*
by: Robert W. Ledeen, et al.
Published: (2008-06-01)

Emerging potentials of nanotherapeutics in breast cancer microenvironment targeting
by: Vaishnavi Gadi, et al.
Published: (2022-11-01)

Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion
by: Nadia Sousa, et al.
Published: (2023-08-01)

Implications of Sphingolipid Metabolites in Kidney Diseases
by: Shamroop kumar Mallela, et al.
Published: (2022-04-01)

Editorial: Bioactive sphingolipids in health and disease
by: Mutay Aslan, et al.
Published: (2022-10-01)

Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
by: Diego Camuzi, et al.
Published: (2019-04-01)

Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling
by: Martin Fan, et al.
Published: (2013-10-01)